[Use of an adenyl preparation for treating neuralgic amyotrophy].
The authors suggest that adenyl should be included into the therapeutic combination used for treating patients suffering from neural amyotrophy. The drug is to be injected intramuscularly twice a day for a month. Observations of 24 patients showed that in 23 of them positive changes could be noted. These changes manifested not only in a subjective, but also in a distinct objective increase of the muscular force and motor potentialities, and even in appearance of weak tendon reflexes in some cases. No side effects were observed.
D000249:Adenosine Monophosphate / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D009133:Muscular Atrophy / Q000188:drug therapy*; D009437:Neuralgia / Q000188:drug therapy*
D000249:Adenosine Monophosphate
Primenenie preparata adenila dlia lecheniia bol'nykh s nevral'noĭ amiotrofieĭ.